TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Instylla Stock

Instylla Stock

www.instylla.com/Healthcare / Medical DevicesFounded: 2017

Instylla is pioneering the development of next-generation liquid embolics for interventional radiology, with a primary focus on interventional oncology and peripheral hemostasis. Based in Bedford, MA, this privately held company is advancing the field through its innovative product, the Embrace™ Hydrogel Embolic System. Designed for controlled, complete, and persistent embolization, Embrace™ aims to significantly improve patient outcomes in these critical clinical areas. Instylla's mission is to restore life, hope, and joy to the world's sickest patients by offering novel embolization solutions that enhance treatment efficacy.

Buy or sell Instylla stockLearn more about Instylla IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Instylla, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Instylla’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Instylla.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Instylla investors also invested in these private companies

Catalyst Health Ventures
Sparta Group
Ascension Ventures
AMED Ventures
Excelestar Ventures
Angel Physicians Fund
Delos Capital Partners
Incept

Team

Management Team

Raymond Lareau
President
Amarpreet Sawhney Ph.D
Founder & Chief Executive Officer

Board Members

Darshana Zaveri
Catalyst Health Ventures
Henry Chen JD
Delos Capital Partners
Tara Butler MD
Ascension Ventures
Tasneem Dohadwala
Excelestar Ventures

Frequently Asked Questions About Instylla’s Stock

plusminus
Can you buy Instylla’s stock?
Instylla is not publicly traded on NYSE or NASDAQ in the U.S. To buy Instylla’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Instylla’s stock?
Yes, you can sell stock of a private company like Instylla. Forge can help you sell your Instylla stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Instylla’s stock price?
Instylla is a privately held company and therefore does not have a public stock price. However, you may access Instylla’s private market stock price with Forge Data.
plusminus
What is Instylla’s stock ticker symbol?
Instylla does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Instylla in the Medical Devices sector

Neuralink

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$3.45B

Synchron

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$400.53MM

HistoSonics

Sector
Healthcare / Medical Devices
 
 

Beta Bionics

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$263MM

Levels

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$310.36MM

CMR Surgical

Sector
Healthcare / Medical Devices
 
 

Imperative Care

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$1.35B

Eko Health

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$268.75MM

Verily Life Sciences

Sector
Healthcare / Medical Devices
 
 

News Highlights

FINSMES 08/16/2023
Instylla Closes $30M Equity Financing
Instylla, Inc., a Bedford, MA-based company developing next-generation liquid embolics for peripheral vascular embolotherapy, closed a $30m financing round. This round was led by new investor Delos Capital, with continued participation from the investor syndicate of Excelestar Ventures, Ascension Ventures, Catalyst Health Ventures, Amed Ventures, Sparta Group, and Incept, LLC.

Trending Companies

Frequently Asked Questions

Updated on: May 2, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.